iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF

IHE

$106.72

Updated: 04/11/2026, 10:42:02

Market Cap
$1.21B
Sector
Financial Services
Industry
Asset Management
Country
US

No historical data available

Company Profile

The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.

USD
AMEX
https://www.ishares.com/us/products/239519/ishares-us-pharmaceuticals-etf
Asset Summaries
Latest generated summaries for IHE

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for IHE.
Share price
$106.72
Market cap
$1.21B
Exchange
AMEX
Currency
USD
CEO
N/A
Employees
N/A
IPO date
05/05/2006
Beta
0.479
Last dividend
$0.00
Day range
$106.39 – $108.15
52-week range
$75.03 – $109.43
1-day performance
-0.19%
1-year performance
42.24%
Current drawdown (1Y)
-2.48%
CIK
0001100663
CUSIP
464288836
ISIN
US4642888360
Created
07/12/2025, 04:42:04
Last update
04/11/2026, 10:42:02

Track iShares U.S. Pharmaceuticals ETF with an AI analyst

See which prediction-market events move IHE, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.